Trials / Completed
CompletedNCT05515471
Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction
A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial to Evaluate the Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 312 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy and safety of SHR8058 eye drops for patients with dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR8058 eye drops | SHR8058 eye drops |
| DRUG | saline eye drops. | saline eye drops. |
Timeline
- Start date
- 2021-02-04
- Primary completion
- 2021-09-07
- Completion
- 2021-09-07
- First posted
- 2022-08-25
- Last updated
- 2022-08-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05515471. Inclusion in this directory is not an endorsement.